CCRNCROSS COUNTRY HEALTHCARE INC

Nasdaq crosscountryhealthcare.com


$ 16.46 $ 0.42 (2.62 %)    

Tuesday, 07-May-2024 15:59:52 EDT
QQQ $ 440.32 $ 0.07 (0.02 %)
DIA $ 388.70 $ 0.29 (0.07 %)
SPY $ 517.26 $ 0.57 (0.11 %)
TLT $ 90.79 $ 0.55 (0.61 %)
GLD $ 214.23 $ -0.99 (-0.46 %)
$ 16.44
$ 16.06
$ 16.43 x 200
$ 0.00 x 0
$ 16.06 - $ 16.94
$ 15.65 - $ 28.75
281,986
na
568.77M
$ 0.47
$ 12.40
TBD
na
na ($ 0.00)
na
TBD na
How to Read 10-K & 10-Q Reports To View SEC Filing Reports, Please Register or Sign In
# Filing Date Period End Date Type Report Link
1 05-02-2024 03-31-2024 10-Q
2 02-23-2024 12-31-2023 10-K
3 11-02-2023 09-30-2023 10-Q
4 08-03-2023 06-30-2023 10-Q
5 05-04-2023 03-31-2023 10-Q
6 02-23-2023 12-31-2022 10-K
7 11-03-2022 09-30-2022 10-Q
8 08-04-2022 06-30-2022 10-Q
9 05-05-2022 03-31-2022 10-Q
10 02-28-2022 12-31-2021 10-K
11 11-04-2021 09-30-2021 10-Q
12 08-05-2021 06-30-2021 10-Q
13 05-06-2021 03-31-2021 10-Q
14 02-25-2021 12-31-2020 10-K
15 11-05-2020 09-30-2020 10-Q
16 08-06-2020 06-30-2020 10-Q
17 05-08-2020 03-31-2020 10-Q
18 03-05-2020 12-31-2019 10-K
19 11-06-2019 09-30-2019 10-Q
20 08-01-2019 06-30-2019 10-Q
21 05-02-2019 03-31-2019 10-Q
22 03-01-2019 12-31-2018 10-K
23 11-02-2018 09-30-2018 10-Q
24 08-02-2018 06-30-2018 10-Q
25 05-04-2018 03-31-2018 10-Q
26 03-02-2018 12-31-2017 10-K
27 11-03-2017 09-30-2017 10-Q
28 08-04-2017 06-30-2017 10-Q
29 05-05-2017 03-31-2017 10-Q
30 03-03-2017 12-31-2016 10-K
31 11-04-2016 09-30-2016 10-Q
32 08-05-2016 06-30-2016 10-Q
33 05-06-2016 03-31-2016 10-Q
34 03-11-2016 12-31-2015 10-K
35 11-06-2015 09-30-2015 10-Q
36 08-06-2015 06-30-2015 10-Q
37 05-07-2015 03-31-2015 10-Q
38 03-06-2015 12-31-2014 10-K
39 11-06-2014 09-30-2014 10-Q
40 08-08-2014 06-30-2014 10-Q
Guide for Analyst Ratings To View Analyst Ratings, Please Register or Sign In
# Date Analyst Firm Upside/Downside Price Target Change Rating Change Current Rating

News

OPINIONS

 barrington-research-maintains-outperform-on-cross-country-healthcare-lowers-price-target-to-21

Barrington Research analyst Kevin Steinke maintains Cross Country Healthcare (NASDAQ:CCRN) with a Outperform and lowers the ...

 benchmark-maintains-buy-on-cross-country-healthcare-lowers-price-target-to-19

Benchmark analyst Bill Sutherland maintains Cross Country Healthcare (NASDAQ:CCRN) with a Buy and lowers the price target fr...

 cross-country-healthcare-q1-2024-adj-eps-019-beats-017-estimate-sales-379174m-beat-374089m-estimate

Cross Country Healthcare (NASDAQ:CCRN) reported quarterly earnings of $0.19 per share which beat the analyst consensus estimate...

 barrington-research-maintains-outperform-on-cross-country-healthcare-lowers-price-target-to-24

Barrington Research analyst Kevin Steinke maintains Cross Country Healthcare (NASDAQ:CCRN) with a Outperform and lowers the ...

 truist-securities-maintains-hold-on-cross-country-healthcare-lowers-price-target-to-16

Truist Securities analyst Tobey Sommer maintains Cross Country Healthcare (NASDAQ:CCRN) with a Hold and lowers the price tar...

 benchmark-maintains-buy-on-cross-country-healthcare-lowers-price-target-to-21

Benchmark analyst Bill Sutherland maintains Cross Country Healthcare (NASDAQ:CCRN) with a Buy and lowers the price target fr...

 cross-country-healthcare-sees-q1-eps-015-025-vs-030-est-revenue-370m-380m-vs-39904m-est

Outlook for First Quarter 2024 The guidance below applies only to management's expectations for the first quarter of

 cross-country-healthcare-q4-eps-029-beats-027-estimate-sales-41404m-beat-40442m-estimate

Cross Country Healthcare (NASDAQ:CCRN) reported quarterly earnings of $0.29 per share which beat the analyst consensus estimate...

 earnings-scheduled-for-february-21-2024

Companies Reporting Before The Bell • Gatos Silver (NYSE:GATO) is estimated to report quarterly earnings at $0.09 per share on...

 jmp-securities-initiates-coverage-on-cross-country-healthcare-with-market-perform-rating

JMP Securities analyst Constantine Davides initiates coverage on Cross Country Healthcare (NASDAQ:CCRN) with a Market Perfor...

CLASS ACTION DEADLINES - JOIN NOW!

NEW CASE INVESTIGATION